Archive for June, 2012

Seeking Alpha Article Features International Stem Cell Corp. (ISCO), Touts Stem Cell Technology’s Bright Future

Friday, June 29th, 2012

In an article published earlier today featuring key players in the stem cell industry, International Stem Cell Corp. was labeled as being possibly “the most promising” as the company has developed a breakthrough technology that provides pluripotent stem cells without using viable human embryos and without the issues associated with induced pluripotent stem cells or adult stem cells. Based upon unfertilized human eggs, ISCO’s technology also allows superior immune-matching capabilities.

The idea behind stem cells has in fact been around for a very long time. Ever since the invention of the microscope and the development of cell theory, scientists have known that somehow the complex collection of specialized cells that make up the human body have their origin in a single fertilized egg. It was clear that, somewhere during the earliest stages of the developmental process, cells were being systematically transformed into specialized heart cells or nerve cells or liver cells or blood cells. The term “stem cell” was used as early as the late 1800s, before anything was really known about particular stem cells, but, by the early 1900s, it was recognized that different blood cells were all parented by a particular stem cell. By the early 1960s, there was a better understanding of the operation of bone marrow cells and the production of blood cells, which eventually led to today’s bone marrow transplants, the transplanting of adult stem cells for the treatment of leukemia and other blood related diseases.

As the technology to grow and work with human cells increased in the late 20th century, human stem cell research took off. Soon the first human embryonic stem cell lines were introduced, which scientists were able to use to fully establish the remarkable abilities of stem cells, suggesting their possible use in generating replacement cells for a broad range of tissues and organs. Since then, researchers have gained a deeper knowledge of the different types of stem cells, how to manipulate them, and the applications for which they can be most effectively used.

To read the entire article, which was written by Tony Daltorio, visit http://seekingalpha.com/article/693441

For additional information on ISCO, visit the company’s website at www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

Ohr Pharmaceutical, Inc. (OHRP) Announces $2.91M Financing through Exercised Series H Warrants

Friday, June 29th, 2012

Ohr Pharmaceutical today announced that its existing shareholders have exercised 5,299,022 Series H warrants at $0.55 per warrant, resulting in net proceeds of $2.91 million.

The company offered shareholders 0.6 replacement warrants for every Series H warrant exercised, resulting in the aggregate issuance of 3,179,410 warrants exercisable at $1.20 for a five-year period; 95 percent of the outstanding Series H warrants were exercised in this transaction.

Ohr Pharmaceutical said it plans on using the proceeds for general corporate purposes, as well as to advance the clinical development of its compounds: Squalamine eye drops for the treatment of wet-AMD and neovascular ophthalmic disorders; and OHR/AVR118 for the treatment of cancer cachexia.

“This financing will allow us to comfortably achieve several upcoming milestones in our Squalamine eye drop and OHR/AVR118 clinical programs in the remainder of 2012 and 2013. We would also like to thank our shareholders for their continued support,” Dr. Irach B. Taraporewala, CEO of Ohr Pharmaceutical stated in the press release.

The Squalamine eye drop program for wet-AMD was awarded Fast Track designation by the FDA, and Ohr Pharmaceuticals will begin a phase II trial in the third quarter of 2012.

For more information visit www.ohrpharmaceutical.com

Let us hear your thoughts below:

CytoSorbents Corp. (CTSO) Blood Purification System Data Featured at Western Thoracic Surgical Association

Friday, June 29th, 2012

CytoSorbents is a therapeutic device company using blood purification to modulate the immune system, reduce severe inflammation, and prevent or treat organ failure caused by life-threatening illnesses. The company today announced the presentation of data from its research collaboration at the Annual Meeting of the Western Thoracic Surgical Association in Hawaii, being held today.

Dr. David Rabkin, assistant professor of Surgery, Division of Cardiothoracic Surgery at the University of Washington Medical Center in Seattle, Wash., will present the potential future use of CytoSorb® blood purification system to protect the viability of organs donated by patients who are officially dead from irreversible brain injury, but whose organs are still working.

“While the vast majority of organ transplants rely on cadaveric donors, it’s long been appreciated that brain death creates an environment hostile to organ function. This effect is particularly pronounced in the heart where estimates suggest that about 20 percent of potential organ donors are excluded from cardiac donation due to the effects of brain death on cardiac function,” Dr. Rabkin stated in the press release.

“One of the components of the body’s reaction to brain death is a surge in inflammatory cytokines which have been shown in other contexts to importantly depress heart function. Using the CytoSorb hemoadsorption technology in a porcine model we demonstrated that cytokine filtration significantly improves heart function after brain death compared to brain dead animals that did not undergo cytokine filtration. This may have important implications for expanding the cardiac donor pool and reducing the increasing disparity between the supply and demand of hearts for transplantation and warrants further study.”

Dr. Chan said the data demonstrates the harmful effect excessive cytokines have on vital organs, and shows CytoSorb’s ability to protect organ function in a potentially important clinical application.

CytoSorb is currently approved to treat excessive levels of cytokines in the EU.

For more information visit: www.cytosorbents.com

Let us hear your thoughts below:

FluoroPharma Medical, Inc. (FPMI) Targets #1 Most Wanted

Friday, June 29th, 2012

In 1950, the FBI formally announced their Ten Most Wanted list to the world, in an attempt to promote the identification and capture of the most notorious fugitives. If there were a ten most wanted health list, coronary artery disease (CAD), still the world’s #1 killer, would be at the top. Several million people die every year from CAD. In the U.S., it is responsible for approximately one third of all deaths. It’s little wonder that the health industry is gunning for CAD in a big way.

However, in spite of huge investments in drugs to fight the disease, it is becoming clear that drugs cannot cure coronary artery disease. Although progress has been made in reducing LDL (sometimes called the “bad” cholesterol, a risk factor for CAD), the fact remains that up to 35% of heart attack patients do not have high blood cholesterol levels, even though most of them have atherosclerosis (hardening of the arteries). In addition, attempts to use drugs to raise the level of HDL (“good” cholesterol) have proven unsuccessful.

The best weapon to use against CAD remains early diagnosis and diagnostic follow-up, using sophisticated technologies such as positron emission tomography (PET) scanning, the best technology for detecting the subtle biological processes associated with CAD and other diseases. And this is exactly the market targeted by FluoroPharma Medical, developers of advanced tracer chemicals needed to make PET effective. FluoroPharma’s two lead products are CardioPET, used for the assessment of myocardial metabolism, and BFPET, used for the assessment of blood flow in CAD patients. They are also developing VasoPET, to be used for the detection of vulnerable plaque in CAD patients.

Studies have shown PET imaging to be cost-effective for CAD management. It can result in a 50% reduction in the use of coronary arteriography and CABG, a 30% reduction in CAD management costs, and excellent short-term patient outcomes, compared with conventional SPECT imaging.

For more information, see the company website at www.FluoroPharma.com

Let us hear your thoughts: FluoroPharma Medical, Inc. Message Board

Spare Backup, Inc. (SPBU) Announces Launch of Mobile Security and Backup Services with Second European Financial Services Group

Friday, June 29th, 2012

Spare Backup, a leading provider of data backup and security software for smartphones, tablets, and PCs, announced plans to launch its services with a second financial services group in Europe as part of a master service agreement with their largest European distributor. Spare Backup is unaffiliated with any carrier or manufacturer. The launch is expected to occur in the next 30 days and will support the strategy of providing services on a private label.

“We are excited to launch our Spare Mobile offerings with a second financial services industry partner as we begin to see some early sales data that supports our efforts in the warranty and mobile insurance space,” commented Cery Perle, CEO of Spare Backup. “Through our private labeled websites we can support multiple launches in a very quick time frame and we intend to diligently work with our partners in North America and other parts of the world to rapidly grow our customer base. We believe we are in the right place at the right time in the mobile space to quickly gain traction and support a very large recurring revenue base for our company to fuel our future growth.”

Partnering with a second financial services group is a key milestone because it validates the ability of Spare Backup to meet the standards for encryption and security mandated by the financial services industry. It also supports the ability to launch services for different industries across the globe. Initial data from the first launch in North America have demonstrated a 30% customer take rate on offerings incorporating Spare Backup services. Management expects similar results for other scheduled launches in North America and Europe.

Spare Backup specializes in helping consumers, small office/home office users, and small to mid-sized businesses protect their computer data quickly, automatically, and cost-effectively. Spare Backup’s flagship software is the first totally automated cloud-based backup service that is distributed on a stand-alone or private label basis through major retail and warranty service partners. Their software enables consumers and small to medium sized businesses to protect computer and mobile data on a continuous basis or according to the schedule of the user’s choice. It also supports the integration of that content across various devices and provides enhanced security features to protect valuable data on any lost or stolen devices.

For more information, please go to www.sparebackup.com

Let us hear your thoughts below:

Telanetix, Inc. (TNIX) Announces Partnership with GreatAmerica to Bundle AccessLine SIP Trunking with Equipment for Business Phones

Friday, June 29th, 2012

Telanetix, a cloud-based provider of next-generation hosted voice services for the business market through its AccessLine branded service, and GreatAmerica Leasing Company announced a partnership that will enable GreatAmerica to bill and collect AccessLine SIP trunking charges bundled with business phone equipment. It is anticipated that the partnership will simplify the process of purchasing business phone services and simultaneously take advantage of cost savings that SIP trunking service provides for businesses.

GreatAmerica looks forward to capitalizing on its invoicing expertise by billing AccessLine SIP trunking charges, along with PBX equipment and software, on its invoices. The company is also excited about enabling telecom dealers and agents who sell AccessLine Voice Services to offer customers a complete communications solution that is easily understood and conveniently billed in a single invoice. In turn, AccessLine considers GreatAmerica to be an ideal partner, due to the company’s shared focus of service and support and its commitment to making the purchase of voice service and equipment easy for customers.

Together, GreatAmerica and AccessLine have created the first consolidated phone system lease payment and SIP trunking bill in the industry, making it simple for dealers and agents to bill phone service, equipment, and software on the GreatAmerica invoice.

Founded in Grand Rapids, Iowa, in 1992, GreatAmerica Leasing Corporation has more than $1.3 billion in assets and is the largest private independent equipment finance company in the United States. The company is committed to helping equipment manufacturers, distributors, vendors, and dealers succeed and retain lifelong customers. Providing equipment financing and consulting services in all 50 states and some U.S. Territories, GreatAmerica employs more than 370 professionals through its offices in Iowa, Minnesota, Missouri, and Georgia. For more information, visit the company’s Web site at www.greatamerica.com.

Leading cloud-based communications solutions provider Telanetix offers cutting-edge voice services to all business market segments. The company’s solutions meet customers’ real-world communications demands with an industry-leading value proposition of next-generation products and technology, bringing enhanced productivity and industry-leading savings to customers. Marketed under the AccessLine brand, the company’s cloud-based hosted telecom voice services provide companies with flexible calling solutions, a simpler installation experience and a superior range of support options. Telanetix has a history of serving more than 100,000 business customers, including Fortune 500 companies, and has scaled its award-winning technologies to meet the needs of small businesses that are entrepreneurially focused. For more information, visit the company’s Web site at www.accessline.com.

Let us hear your thoughts below:

Emmis Communications Corp. (EMMS) Selects TuneIn to Broaden Market Reach

Friday, June 29th, 2012

Yesterday, TuneIn announced that it has been selected by Emmis Communications to broaden the reach of its 20 stations to the service’s 30 million monthly active listeners. As part of the agreement, Emmis will gain use of a variety of TuneIn tools, such as free analytics and an ad platform. Emmis stations will also promote TuneIn to their listeners on-air.

“One of our key focal points is to connect the highest quality broadcasters with the millions of passionate listeners who look to TuneIn to hear their favorite content and discover great new stations and artists,” said John Donham, CEO, TuneIn. “Emmis has such a compelling stable of influential radio stations, and as an organization they really understand the value of great programming and strong brand-building. We are very excited to align with them.”

Emmis owns and operates radio stations in the nation’s largest markets, including New York, Los Angeles, Austin, St. Louis, and Indianapolis, its hometown. TuneIn listeners now can enjoy popular Emmis stations through over 150 different platforms, including smartphone and tablet apps, connected vehicle dashboards, Internet home entertainment systems, and online at www.tunein.com. Currently, TuneIn Radio and TuneIn Radio Pro are the only audio streaming apps that have a 4.5 or 5 star rating on every mobile platform, worldwide.

Jeff Smulyan, Chairman and CEO of Emmis Communications, remarked, “Emmis is excited by today’s announcement. We want to follow our listeners and deliver our content to the platforms they choose to use. The TuneIn platform will provide our listeners from coast to coast another connection point with their favorite radio brands.”

Signs of the alliance were evident earlier this month when Emmis offered the entire HOT 97 Summer Jam festival available for free through TuneIn’s service. Emmis also offered theme stations celebrating the music of HOT 97 Summer Jam and the POWER 106 Powerhouse festival exclusively to TuneIn listeners. TuneIn and Emmis-owned KGSR/Austin worked closely together in March as KGSR streamed numerous live performances from SXSW to the TuneIn audience.

Let us hear your thoughts below:

GSA Advances Green Power Adoption and Significant Energy Savings through World Energy Solutions, Inc. (XWES)

Friday, June 29th, 2012

World Energy Solutions, a prominent energy management services firm, announced that it has assisted the U.S. General Services Administration, Region 2, in the procurement of approximately 300 million kWh of electricity. The procurement includes multiple GSA facilities in New York, in addition to other federal accounts, including the American Red Cross, Bureau of Prisons, United Nations, U.S. Coast Guard, and U.S. Department of Veterans Affairs.

In a battery of competitive online auctions on the World Energy Exchange ®, GSA tested several products and terms in a reasonable and transparent manner, accumulating 127 bids from six suppliers throughout the process. The auctions brought in new contracts that are expected to result in over $10.8 million in savings relative to the prior agreements of the participating agencies. Delivery will begin in May 2012 under the new terms.

Markedly, GSA awarded two-year power contracts for its Manhattan and Upstate Service Centers. It is anticipated that these contracts will result in annual savings in excess of $3 million and $750,000. The Manhattan Service Center was able to achieve savings of this magnitude while purchasing exclusively green energy. Additionally, GSA’s Upstate Service Center was able to up its green energy percentage to 7.5% from its previous value of 0%.

Through the auctions, each participating agency secured green power while reducing energy costs, further burnishing GSA Region 2’s credentials in environmental leadership. In 2011, GSA Region 2 won a coveted GSA Achievement Award for Real Property Innovation in sustainability. GSA has been notified it will receive a similar award again in 2012 for continuing to lead by example.

“It is very gratifying to help GSA Region 2 and other participating federal agencies in New York capitalize on historic lows in the market to save money and green their portfolios,” said Jonathan Harvey, Vice President, Government, at World Energy Solutions. “Each time we do this — and we’ve been working together now for 10+ years — we see how well our procurement process works, the competitive dynamics it fosters and the strong supplier participation it elicits. GSA continues to lead the way in energy procurement, delivering great results to its constituents in a fair and transparent manner.”

Added Phil Adams, CEO of World Energy Solutions: “Under the careful stewardship of Ken Shutika and Brian Magden, GSA Region 2 has set the gold standard for energy procurement. The proof lies in the numerous awards they have won — and keep on winning — and the millions of dollars in electricity-rate savings and green power they continue delivering to a growing number of federal agencies and facilities.”

Yesterday’s deal marks the latest success for World Energy and GSA under the terms of a 5-year energy management contract the two executed in 2010. That contract provides supply-side energy procurement and management services to the GSA’s Energy Division for its extensive network of federal government agencies and runs through September 30, 2015.

For further information, please visit www.worldenergy.com

Let us hear your thoughts below:

Mass Megawatts Wind Power, Inc. (MMMW) Begins Construction of New Patent-Based Wind System

Thursday, June 28th, 2012

Mass Megawatts Wind Power today said it has commenced construction of a demonstration, low-cost wind system that utilizes the company’s patented wind augmentation technology, the Multi-Axis Turbo (MAT). To further demonstrate its technology’s potential, the company also announced that it will install a wind unit without the new low cost augmenter next to the augmented system to prove the MAT’s ability to lower the cost of producing wind-generated electricity.

Mass Megawatts’ wind augmentation system was designed to increase by 70 percent the wind velocity directed at the turbine, which the company says subsequently triples the increase in the electrical power generated by the turbine.

MAT ranges between 50 and 80 feet in overall height; by proving its efficacy in shorter heights, the company can eliminate the notion that turbine structures need to exceed that height to realize adequate wind velocity. Reducing the size of wind turbines reduces material and installation costs; can result in expediting zoning approval; and also allows the turbine to operate profitably in lower wind-speed locations.

Because of its use of horizontal or propeller type turbine blades, Mass Megawatts said the per rated kilowatt is projected to be less than $1,000 and anticipated to approach $600 in mass production compared to traditional wind power systems ranging between $1,500 and $2,000 per rated kilowatt.

For more information visit www.massmegawatts.com

Let us hear your thoughts below:

Access Pharmaceuticals, Inc. (ACCP) Presents Positive Data of MuGard Phase 4 Clinical Trial at Cancer Symposium

Thursday, June 28th, 2012

Access Pharmaceuticals today said that Dr. Ron R. Allison of Carolina Radiation Medicine, Greenville, NC, recently presented results from the company’s ongoing MuGard phase 4 clinical trial in oral mucositis at the Multinational Association of Supportive Care in Cancer (MASCC) Conference in NYC, presenting summarized data from 70 cancer patients undergoing chemoradiation therapy for head and neck cancer.

Data shows that patients using MuGard experienced statistically significant efficacy in: reduction in mouth and throat pain, a common side effect of chemotherapies; a delay to onset of oral mucositis, a debilitating side effect of some radiation and chemotherapy cancer treatments; and reductions in weight loss during therapy and in the use of opioid pain medication.

“Given the significant oral mucositis typically seen in this head and neck cancer population, the benefits of MuGard shown in the results from this trial are important both clinically and from a patient quality-of-life perspective. It’s critically important that we keep patients as comfortable and nourished as possible during this tough treatment regimen, to optimize clinical outcomes,” Dr. Allison stated in the press release.

Jeffrey B. Davis, president and CEO of Access Pharmaceuticals, detailed two key values of MuGard, per current clinical trials.

“Access believes this MuGard data is ground breaking and unique from at least two perspectives. First, this is the first product that has ever shown a statistically significant positive clinical benefit in managing the pain symptoms and delaying the onset of oral mucositis in the very difficult to treat head and neck cancer population,” Davis stated. “Second, the rigorous design of the MuGard trial is the first of its kind in a medical device treatment option for oral mucositis, setting a new standard in this area. The clinical and quality-of-life benefits shown in this data echoes what we hear in the marketplace and that is evidenced in the increasing commercial adoption of MuGard.”

For more information visit www.accesspharma.com

Let us hear your thoughts below:

ERF Wireless, Inc. (ERFB) Introduces a GPS-Based e911 Solution for Oil and Gas Clients to Safeguard Remote Drilling Operations

Thursday, June 28th, 2012

ERF Wireless, through its subsidiaries (Energy Broadband Inc., ERF Enterprise Network Services, ERF Wireless Bundled Services, ERF Wireless Messaging Services, and ERF Network Operations) has developed an impressive array of wireless broadband technologies/service offerings, including the biggest terrestrial wireless network in the country for handling the needs of the oil and gas exploration sector, announced a specialized, GPS-based e911 system for their wireless network services today via subsidiary Energy Broadband.

With a majority of revenue streaming in directly from providing mission critical, terrestrial wireless broadband communications to domestic oil and gas rigs operating in remote areas, this awesome new feature brings a whole new meaning to the phrase that is typically used to describe the company’s already widely acclaimed services (including VoIP), “best of class.”

It cannot be stressed how important emergency 911 is for these kinds of remote operations. There are often no marked roads or at best a newly cut work road; typically there isn’t even a physical address, making emergency relief via standard 911 unavailable (even if there is a physical address it probably won’t be located on any available map). But now that this breakthrough technological advancement is being rolled out, we have real-time GPS coordination that is extensible to a variety of mapping methods, making it very simple to provide (often potentially life-saving) support for protecting rig-site workers.

Talk about a huge draw for oil and gas developers, this e911 system that marries the VoIP telephones already deployed on the work site to dispatch-ready GPS capabilities closes the loop between accident/injury and care, one of the biggest concerns for any developer doing business at a remote (often dangerous or difficult) location. The ability to provide this umbrella of protection for workers, where it was previously not available or possible, will draw in even more of the sector to EFRB, helping to cement the company’s already strong market position.

CEO of EFRB, Dr. Dean Cubley, sighted this latest development as a clear indication to oil and gas developers that the company remains committed to providing the premier communication services envelope to their rapidly growing customer base.

One can easily imagine site foremen breathing a sigh of relief, knowing that when and if the unthinkable happens, emergency services are just a phone call away and the personnel can get right to them with any simple GPS-enabled device using those coordinates. The name ERF Wireless should spread ever more rapidly throughout the sector as a result of this advancement. The broader enterprise, commercial, and residential markets served both domestically and internationally by the company and its subsidiaries are well aware of this tireless drive for innovation by ERFB.

ERFB management has 40 years of work in wireless broadband, as well as network integration, triple-play FTTH (fiber to the home), IPTV, and sophisticated content delivery methods. Employing bleeding-edge technology and the company’s proprietary CryptoVue® Network Security Appliance, ERFB has already made big waves in the banking industry (over 100 locations across three states), where the competitive edge the company is able to assert has crushed expensive T1 telephony solutions. Initiatives like the recent expansion of the product portfolio to include luxury resort community-targeted triple-play Voice, Video, and Internet system, combined with a rich menu of wireless broadband services, has enabled ERFB to create a dynamic, appealing turnkey solution that can be rolled out to global markets with ease.

Yes, the already impressive wireless network coverage available to customers in hydrocarbon rich development areas like Texas, New Mexico, Oklahoma, and Louisiana has just gotten much safer and much better, thanks to ERFB.

For more information on the GPS-based e911 service, or to learn more about ERF Wireless, Inc., please visit the company’s websites at: www.ERFWireless.com and www.ERFWireless.net

Let us hear your thoughts below:

Norman Cay Development, Inc. (NCDL) is “One to Watch”

Thursday, June 28th, 2012

During the September month of last year, via a share exchange agreement, Norman Cay Development acquired all outstanding shares of Discovery Gold Ghana Limited for a $100k lump sum and issuance of 17.5M newly-issued shares to DGG stockholders. The company thereby obtained access to the exclusive option held by DGG with rights to acquire, explore, and develop the Edum Banso (7.8 square miles) gold project in Western Ghana (specifically the historic Ashanti Gold Belt, Mpohor Wasa East District). DGG currently holds a 65% interest with an opportunity to acquire up to 90% in these exclusive exploration rights.

Norman Cay takes the stage alongside the big boys, like global gold developer Newmont Mining (who now has some 20% of their overall footprint in resource rich Ghana), with a key property that is ideal for such an emerging gold developer. DGG, which is now a wholly-owned subsidiary of NCDL, is organized under the laws of the country of Ghana and so NCDL is already in a very favorable position with regard to the Ghanian government for advancing the highly prospective Edum Banso project.

As of June 13, NCDL has reported receiving approval by the Minerals Commission of Ghana of the assignment of option rights for Edum Banso, clearing the way for future development, as this assignment of the option rights from Xtra-Gold Mining Limited to DGG was the final acquisition agreement obligation to be fulfilled. The option transfer transaction was subject to a nominal fee (already paid and receipt taken) to the Minerals Commission and will produce key, formal Ministerial consent by mid-July 2012, according to the company’s Ghana legal counsel.

NCDL is big on Ghana gold and has devised a regional strategy focused on Edum Banso. Now that the Minerals Commission transfer approval process is completed, an aggressive funding/exploration initiative will be pursued, targeting the previously identified areas. Phase I of the 2012 exploration program will include extensive geological mapping efforts, as well as soil sampling, assay, and the necessary subsequent analysis required in order to validate previous efforts on the concession by both Xtra-Gold (in 2008) and Newmont Gold (2004).

The company will try to line up perfect vectors for Phase II trenching and auger sampling, looking to take full advantage of the well-established profile offered by extant workings. In general the exploration program (outlays projected at some $970k over the next 12-month period) will seek to extend the data sets already assembled via the previous aeromagnetic analysis, as well as some 5,782 soil/stream sediment samples, 319 meters of trenching, 252 auger drill holes, and 81 rock chip samples taken. The goal is to flesh-out the four distinct mineralization zones occurring across the roughly 5 mile by 2k-foot area, which includes contact with the same source behind the nearby (just over half a mile away to the SE) HBB Father Brown and Adoikrom open pit operations (around 180k ounces per year) of Golden Star Resources, the distinct Mpohor Complex mafic intrusions.

This is a great spot to be developing and other nearby producers, like the Adamus Resources/ Endeavour Mining, multi-million ounce Nzema Gold Mine (100k ounces per year), offer a tantalizing indication of the kind of news to potentially look forward to out of the company’s 2012 exploration program at Edum Banso. Needless to say that some 5 mile by 2k-foot mineralization area will provide ample opportunity for Phase II bedrock seeking, and with a known gold geochemical profile, preparations for a 15-30 hole Phase III drilling campaign is expected to go swimmingly.

The company will shrewdly employ the best efforts of their Ghana-experienced technical consulting firm and should have Phase I wrapped within 90 days of kick off. Norman Cay is looking at some very exciting times in the immediate future and has really plowed into the mission, grabbing 30-year veteran of the mining industry Steven E. Flechner for the President and CEO position. The Flechner appointment should tell investors everything they need to know about just how serious NCDL is regarding their Ghana gold strategy. Flechner has extensive management experience throughout the industry, as well as on projects in Ghana and was VP/General Counsel for Gold Fields Mining Company from 1978-1993 (U.S. subsidiary of former giant Consolidated Gold Fields), overseeing massive, 100-fold growth in the company’s personnel base and extensive, 400k ounce/year, highly-profitable mining infrastructure (Ortiz, Mesquite, and Chimney Creek mines) that was later acquired by Newmont Mining.

This is the portrait of a truly assertive emerging gold development company and NCDL is obviously committed to putting the tools and talent into the field to make the CAPEX work for shareholders, so it will be very interesting to see what kind of data comes out of their upcoming exploration program at Edum Banso. With successful open pittable resources being developed in close proximity and a solid geological roadmap that even hits known, producing targets, it should just be a matter of time before we see some serious color.

In a world of increasing uncertainty, where major currencies are under fire from sustained debt pressure, it is easy to see how all roads lead to gold and precious metals as a store of value. Moreover, the intractable nature of sovereign debt crises, has sparked a wave of gold buying by central banks around the world, which are moving to hedge against both general market pullback potential and increased exposure to commodities.

Let us hear your thoughts below:

SmallCapVoice: Victory Resources Corp. (VRCFF) Announces $5 Million Financing Commitment

Thursday, June 28th, 2012

Victory Resources Corp. is pleased to announce that it has entered into an agreement with GEM Global Yield Fund Limited (“GEM”) for a $5.0 million CDN financing commitment. Funds raised through this facility will be used for the ongoing drill program and the subsequent engineering work to bring the Reforma mine to feasibility. Funds will also be used for the development of the Company’s recently optioned Boleo property in Mexico, the Toni property located near Merritt, B.C., as well as general working capital.

Victory Resources Corp. will control the timing and maximum amount of any private placement under this agreement, and has the right, not the obligation, to drawdown on available funds. As part of the financing commitment, the Company has agreed to issue 5 million warrants to GEM in conjunction with each private placement. The warrants will be exercisable for a period of three years from the closing of each private placement at an exercise price of $0.72 CDN per share.

“We are very excited to have entered into this agreement with a world class investment group like GEM. The $5 million facility will assure that our company has access to capital beyond our current drill program,” said Wally Boguski, president and CEO. “We look forward to the results of our ongoing drill program on the Reforma mine as well as the results from the drill program on the tailings pond from the historic Reforma mine operations.”

Let us hear your thoughts below:

BioDelivery Sciences International, Inc. (BDSI) Demonstrates Positive Results in Recent Study

Thursday, June 28th, 2012

BioDelivery Sciences International recently completed an FDA recommended trial as part of the New Drug Application (NDA) to examine the effects of multiple BEMA Buprenorphine/Naloxone (BNX) films administered concurrently. Results of the pharmacokinetic study were positive, indicating that the NDA is on track for submission in early 2013. BDSI expects to have key data from the study in the third quarter of 2012, and the final clinical requirement for an open label study will be initiated at this time.

The intention of the study was to examine dose proportionality ahead of the forthcoming pharmacokinetic study. The results confirmed that the buprenorphine pharmacokinetics were nearly identical following multiple BNX films applied at one time compared to an equivalent dose administered as a single film. Additionally, a linear relationship was found in buprenorphine pharmacokinetics across the dose range of BNX administered, meaning that as doses of BNX increased, there was a corresponding increase in the amount of buprenorphine in the plasma. The study also demonstrated that the exposure of naloxone is similar to the reference standard, Suboxone, which provides additional confidence that the doses selected for BDSI’s upcoming pivotal pharmacokinetic study for BNX will produce similar buprenorphine pharmacokinetics as the reference standard. This pivotal pharmacokinetic study is a critical component of the NDA.

“We are pleased to have again demonstrated the ability of our BEMA drug delivery technology to provide solid dose proportionality,” said Dr. Andrew Finn, Executive Vice President of Product Development. “The outcome of this study not only satisfies the FDA’s request for a multiple film evaluation, but it also enhances the probability of success for BNX in our upcoming pivotal pharmacokinetic study versus Suboxone.”

Nearly 2 million people in the US are dependent on prescription opioids according to the 2010 National Survey on Drug Use and Health, conducted by the U.S. Department of Health and Human Services. Suboxone was approved in 2002 and currently generates annual sales of more than $1.2 billion, growing over 20% in 2011 according to data from Wolters Kluwer, and has been shown to be a highly effective treatment option. BDSI believes that BNX, which uses BDSI’s proprietary BEMA delivery technology, has the potential to offer advantages over Suboxone and could capture significant market share.

BioDelivery Sciences International, headquartered in Raleigh, NC, is a specialty pharmaceutical company that leverages patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics. BDSI focuses on developing products that meet unmet patient needs in the areas of pain management and oncology supportive care.

BDSI’s pain franchise currently consists of two products utilizing the patented BEMA technology:

• ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada, and the E.U. (where it will be marketed as BREAKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer. The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.).

• BEMA Buprenorphine is being developed for the treatment of moderate to severe chronic pain and is in development in a high dose formulation with naloxone for the treatment of opioids.

For more information, visit www.bdsi.com

Let us hear your thoughts below:

GlobalWise Investments, Inc. (GWIV) Hits Home Run with Sycle.net

Thursday, June 28th, 2012

In a recent interview that Hearing Review had with Sycle.net, a GlobalWise channel sales partner, it was clear that Sycle.net was especially enthusiastic about eDocs, the just launched cloud-based document management system developed in partnership with GlobalWise subsidiary Intellinetics.

Sycle.net is the largest provider of cloud-based ERP (Enterprise Resource Planning) software systems specifically designed for the hearing care industry. They support over 65% of the audiology clinics in the U.S., and are growing by approximately 50 clinics every month. The company spent many months researching to identify the right ECM (Enterprise Content Management) software provider to help Sycle’s customers get a handle on all the patient documents naturally associated with health care environments. As their CEO, Ridge Sampson, stated: “Nothing is more important than our reputation with our audiology clients”. Their final choice was GlobaWise, and their Intellinetics Intellivue software platform. There were a number of factors involved in the choice, but one was the ability to easily and seamlessly integrate the Intellivue software platform into pre-existing software systems such as Sycle.net’s.

eDocs enhances the ability of authorized Sycle.net clients to access patient documents wherever there is Internet access. For example, eDocs allows an individual user to leave work, go home or travel, and then later use their own computer or other point of access to have all updated patient documents in front of them. It’s not only tremendously flexible, it’s a big step in freeing up storage space, making the entire business environment easier to manage. One of the early users of the system spoke of the major efficiencies gained by accessing clinical records using their fleet of iPads, and talked about being able to process over 14,000 documents in only 20 business days.

All of this represents a big win for GlobalWise, both now and in the future. Sycle.net serves over 6,000 audiology clinics and 18,000 individual users, providing an unbeatable opportunity for the company to rapidly expand the installed client base.

To see the complete interview, visit http://www.hearingreview.com/issues/articles/HPR_2012-05_04.asp

For additional information on GlobalWise Investments, visit the company’s website at www.GlobalWiseInvestments.com

Let us hear your thoughts: GlobalWise Investments, Inc. Message Board

Duma Energy Corp. (DUMA) is ROI Oriented

Thursday, June 28th, 2012

Duma Energy is a Houston-based oil and gas exploration and production company that leverages 3D seismic data and other technologies to identify and exploit new and underexplored domestic locations, both on and off-shore. They focus on known domestic reserves, seeking accretive acquisitions of production, reserves, or other oil/gas companies that have the highest potential. The company currently has working operations in Texas, Louisiana, and Illinois.

Duma’s strength is their flexibility. The company invests for strong financial returns, not solely for barrels of oil. They are not bound to any particular geographical locations or operational strategy. Risk is evaluated based upon operation considerations, finances, and industry. They concentrate on only industry standard and time-tested technologies, using as a foundation the extensive experience of their senior leadership. They know what works. They carefully avoid unproven resource plays or other superficially attractive opportunities that depend upon high commodity prices. They prefer to let others risk their money first, and learn from their mistakes.

• Duma is actively producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana.
• They seek aggressive growth through acquisition, existing reserves, and drillable prospects.
• The company has a very strong insider commitment, with CEO and insiders providing more than 75% of the capital invested since inception.
• They are pursuing transformational projects with risk-adjusted, high return on investment (ROI) opportunities.

Duma produced 38,000 barrels of oil equivalent (boe) in fiscal 2011, and has already produced more than 45,000 boe in the first half of fiscal 2012. The company has over $77 million in proven resources, with less than $12 million as booked reserves. Domestic production is projected to exceed 1,000 boe per day by the end of 2012, with 2,500 boe per day by the end of 2013.

For additional information, visit the company’s website at www.DUMA.com

Let us hear your thoughts: Duma Energy Corp. Message Board

International Stem Cell Corp. (ISCO) Creates Transplantable Human Cornea from Pluripotent Stem Cells

Thursday, June 28th, 2012

International Stem Cell Corporation’s research and development team has successfully created a functional and transplantable human cornea by developing a new method to derive corneal endothelium-like cells from human pluripotent stem cells.

This major milestone represents a significant step towards the creation of complete cornea tissue that can be used for transplantation. The accomplishment also supports prior data showing indications of corneal endothelium generated by ISCO’s collaborators at Sankara Nethralaya Eye Hospital, India. Such cells by themselves could promote wound healing and regeneration of the cornea, as well as be used as a standalone medical treatment.

ISCO stated that development and commercialization of its cell-derived cornea tissue, along with manufacturing of Lifeline Cell Technology’s media and cellular products, is the foundation for the company’s expansion to the Asian markets and for clinical collaboration with Indian biomedical organizations, including Sankara Nethralaya Eye Hospital and All-India Institute for Medical Sciences.

Asia represents a huge potential growth market for ISCO’s Cornea program. In just India alone there are more than 4 million people suffering from corneal vision impairment with limited access to corneal tissue. International Stem Cell Corporation intends to work with its clinical affiliate in India to meet this healthcare demand.

Dr. Ruslan Semechkin, Vice President of Research & Development, stated, “This new method not only brings our cornea program closer to clinical use, but it also gives us additional licensing opportunities. We have made good progress towards our goal of creating usable corneas, however the additional work, necessary to prove that these endothelium-like cells can be fully functional, will be done in conjunction with our collaborators.”

For additional information, visit the company’s website at www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

BioClinica, Inc. (BIOC) and C.R. Bard Receive Microsoft Life Sciences Innovation Award

Thursday, June 28th, 2012

BioClinica, a provider of clinical trial management solutions worldwide, announced that, along with C.R. Bard, it has won Microsoft Corporation’s prestigious Life Sciences Innovation Award. The award honors companies that utilize Microsoft solutions in the realization of business and information technology benefits, and it is presented at the Drug Information Association’s (DIA) 48th Annual Meeting in Philadelphia. BioClinica was given the award for its success in revolutionizing medicine development by helping clients usher therapeutic innovations into the market quicker, fight serious ailments, improve healthcare, and enhance people’s quality of life.

“Now more than ever, the life sciences industry is faced with many challenges including cutting costs and bringing new drugs and therapies to market faster,” said Andrea McGonigle, national managing director, Life Sciences, Microsoft Corporation. “We are impressed with how the winners demonstrate sustainable impacts through technology, and are proud that Microsoft’s software plays an important role in enabling these achievements in life sciences.”

Specifically, BioClinica was acknowledged for the “Monitor Visit Report” capability of its OnPoint Clinical Trial Management System, developed for C.R. Bard. The presence of this capability makes it much easier for clinical site monitors to record crucial study information. The synchronization of local Word documents through SharePoint transforms the data into a connected list, which is then transferred and updated within OnPoint CTMS. This automated synchronization gives site monitors the power to complete forms from any location, always benefiting from maximum “local quality” intelligence, and will result in time savings on the magnitude of thousands of hours, while significantly reducing trial costs.

BioClinica and C.R. Bard were chosen for this award by a panel of industry experts from a collection of life sciences corporations in the pharmaceutical, biotechnology, and medical device industries that are creatively applying technology to develop therapeutic innovations.

“We are honored to have C.R. Bard and BioClinica receive this award in recognition of our partnership to bring new innovations to market. The power of being able to run a clinical trial from one’s Microsoft Outlook client is extremely powerful as visit reports, open action items, clinical documents and monitoring visits are available everywhere, anytime. The moment you connect to a network everything is instantly updated, something which no other CTMS or clinical suite of products has the power to do,” said Peter Benton, President, eClinical Division of BioClinica.

For further information, please visit www.bioclinica.com

Let us hear your thoughts below:

JWC Acquisition Corp. (JWCAU) and The Tile Shop to Form Tile Shop Holdings Venture

Wednesday, June 27th, 2012

JWC Acquisition Corp. and The Tile Shop, LLC, a specialty retailer of manufactured and natural stone tiles and related accessories, today announced their agreement to combine business under a new holding company, Tile Shop Holdings Inc., which intends to apply for listing on the Nasdaq Stock Market under the symbol “TTS” upon the closing of the business combination.

The Tile Shop currently operates 61 specialty retail stores in 20 states, with eight of the stores opened in 2012. Through its merger with JWC, The Tile Shop says it is positioned to leverage greater access to capital to further execute on its profitable long-term growth strategy. The company intends to open an additional five stores in the remainder of 2012 and expects to open no less than 15 stores in 2013.

“This transaction marks the next step in The Tile Shop’s evolution into the leading North American specialty retailer of tile. As a public company, we not only will continue with our self-funded store growth across the country, but also be better positioned to take advantage of additional resources to accelerate our growth as the demand for our products increases,” Bob Rucker, CEO and founder of The Tile Shop, stated in the press release. “The agreement with JWC Acquisition Corp. supports our ability to pursue attractive growth opportunities in both current and new markets. As we continue to expand and gain market share in this highly-fragmented market, we should be able to increase both sales and cash flow, which will enhance our profitability over time.”

The Tile Shop has thus far demonstrated its ability to mature, as represented by store expansion and revenue growth. The company reported net sales of $152.7 million for the year ended December 31, 2011, an increase of 12.8 percent vs. $135.3 million in 2010. Adjusted EBITDA of $42.6 million represents an increase of 10.7 percent vs. $38.5 million in 2010.

From 2007 through 2011, The Tile Shop has achieved net sales and Adjusted EBITDA increases at compounded annual growth rates of 8.2 percent and 13.3 percent, respectively, driven by new retail locations and increases in same store sales.

The Tile Shop’s net sales for the quarter ended March 31, 2012, increased 21.1 percent to $45.9 million compared to $37.9 million in the first quarter of 2011.

For more information visit www.tileshop.com

Let us hear your thoughts below:

Cuticonsai Group of Italy Completes Field Testing of Start Technologies, Inc.’s (GWBU) FEED Device

Wednesday, June 27th, 2012

Great Wall Builders Ltd., operating as “Start Technologies Europe s.r.o.”, today announced the completion of field tests conducted on its Start Fuel Efficiency and Efficiency Device (FEED) technology.

The Start FEED technology reduces emissions and saves fuels. Testing of the product was done by Cuticonsai Group of Italy, which reported that the technology successfully increased operating profits by achieving an average 8 percent fuel savings, and it meets strict European Low Emission Zone (LEZ) requirements.

Cuticonsai, provider of transportation services for commercial goods, construction material, and waste management services in Italy, has ordered an additional 100 Start FEED units priced at 1,125 Euro per unit.

Cuticonsai is a member of the “National League of Cooperatives and Mutual” (Legacoop), which is active in industry sectors including distribution, construction, agro-food, services, manufacturing, insurance, finance, and credit. Legacoop assists and protects the cooperative with developing economic strategies and policies, and adheres to the ACI, International Cooperative Alliance.

While Cuticonsai’s relationship with the league may appear to support the progression of GWBU’s efforts, GWBU noted that its agreement is with Cuticonsai, not Legacoop.

“Working with Cuticonsai and the national Legacoop group is an important first-step entering the Italian trucking industry and proving our technology to the global market,” Daniele Brazzi, CEO and president of GWBU stated in the press release. “We look forward to reporting on our strong and continued business development activities over the coming days and weeks.”

For more information visit www.StartTechnologiesCorp.com

Let us hear your thoughts below:

PowerSecure International, Inc. (POWR) Receives Contracts Worth $15 Million for Power Projects

Wednesday, June 27th, 2012

PowerSecure International is a leading provider of energy and utility technologies to electric utilities and their industrial, commercial, and institutional customers. The company provides products and services in the areas of: energy efficiency, interactive distributed generation, and utility infrastructure.

The company announced today that it has received $15 million worth of new contracts for its Interactive Distributed Generation (IDG) smart grid power systems and utility infrastructure projects. The new IDG system awards total $10 million and include installations for hospitals and data centers along with pharmaceutical and industrial facilities. The utility infrastructure contracts total $5 million and include transmission system and substation projects for utilities and large industrial customers.

All of these contract awards are for turnkey sales of products and services. PowerSecure states that approximately 80 percent of the revenue is expected to be realized in the second half of 2012, adding to the revenue backlog for the company. The remaining 20 percent of the revenue from these contracts will be recognized during the first half of 2013.

The CEO of PowerSecure, Sidney Hinton, was very pleased with the recent contract awards particularly with the “continuing traction in the hospital, data center, and pharmaceutical markets.” He added that the “sales and marketing teams focused on these customer categories are making terrific progress.” The company continues to be bullish on the opportunities it has to serve these large and growing markets with its proprietary IDG solutions.

For further information about PowerSecure International and its IDG products and services, please visit the company’s website at www.powersecure.com

Let us hear your thoughts below:

Consorteum Holdings, Inc. (CSRH) to Deliver New Innovative Telecommunication and Financial Transaction Services through Joint Venture Agreement

Wednesday, June 27th, 2012

Consorteum, Inc., a wholly owned subsidiary of Consorteum Holdings, Inc., a provider of technology solutions to companies and organizations looking to expand their methods of processing payment transactions, just announced its intent to join forces with Marksal Communications, Inc., one of Canada’s leading providers of global communications solutions, in order to meet the growing demand for next-generation telecommunication and financial transaction services across the North American and International markets.

By combining the technical innovation of Consorteum’s payment processing solutions with the significant capability of Marksal to provide secure communications to remote regions, the anticipated joint venture would provide customers with new capabilities to deliver payment and banking services in areas that traditionally have been underserved. Together with Consorteum’s new focus on mobile application delivery of secure financial transactions, the new joint venture will allow the delivery of next-generation telecommunication and financial services anywhere in the world.

“This new joint venture will allow both companies to leverage their core competencies to better serve their customers,” commented Craig Fielding, CEO of Consorteum, Inc. “This alliance with Marksal Communications provides the ability to deliver secure financial transactions to areas traditionally isolated, and it opens up a tremendous market for new services while facilitating economic growth.”

“This joint venture with Consorteum is very exciting and will provide a unique solution for the delivery of secure financial transactions,” added William MacDonald, CEO of Marksal Communications, Inc. “Marksal is very committed to delivering their expertise and solutions, anywhere in the world, in this new joint venture.”

Under the proposed joint venture, Consorteum will contribute its proven payment solutions and Marksal will provide the communications infrastructure necessary to link remote areas into secure telecommunication and financial services, thus creating an overlay of new, sophisticated financial networks. According to today’s release, Consorteum Holdings will own 51 percent of the joint venture, and Marksal will own 49 percent of the joint venture.

For more information about the company, visit www.consorteum.com

Let us hear your thoughts: Consorteum Holdings, Inc. Message Board

RXi Pharmaceuticals Corporation (RXII) Video Chart for Wednesday, June 27, 2012

Wednesday, June 27th, 2012

Even though RXII has only been trading for less than two months, the technicals show that a base has formed and that there is potential for a move in the near term as the moving averages have converged and the bollinger bands are tightening. Technical traders will be watching for an increase in volume to hold support at 8 cents and for pressure to try and take out resistance at 9 cents.

To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts

Let us hear your thoughts below:

GlobalWise Investments, Inc. (GWIV) Continues to Drive International Expansion with Channel Partner Strategy

Wednesday, June 27th, 2012

GlobalWise Investments, Inc. and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today provided investors with an update on the company’s progress to date and near term intentions to expand into international markets.

For nearly two decades, Intellinetics has focused primarily on domestic United States markets, selling ECM software services through a traditional, direct sales force. This strategy has served Intellinetics well, but the original father-son management team of Matthew and Michael Chretien saw the opportunity to expand the business by hiring international executive William J. “BJ” Santiago. Recruited from Lexmark, Mr. Santiago was brought on to lead the new cloud-based ECM software enterprise and expand the company’s distribution through a one-to-many strategy utilizing Channel Partners who already have a tested and proven model to sell hardware or software related services.

Eight new Channel Partners have been brought on in just the past seven months to continue software sales expansion in the United States, as well as pursue new opportunities internationally. This Channel Partner strategy has shown it is possible to distribute ECM software services in every industry. By utilizing distribution partners who already have an extensive sales force and customer base, GlobalWise is able to focus on being a software company while the Partners emphasize on client sales and on-going support.

Recently, the company announced an agreement with SOIN Integrales (www.soin.co.cr), headquartered in Costa Rica, who dominates the Latin America market selling high-end ERP solutions from companies like Oracle, SAP, and Sybase. Historically, SOIN did not have an ECM (Enterprise Content Management) practice within their software product offerings. However, similar to the US, Latin America is rapidly adopting digital management of document and records for compliance and privacy regulation and historically did not have a cost effective ECM solution.

Today, through the Intellinetics On-demand Solution Store™ templates, SOIN can capitalize on this untapped small to medium sized client base through an exclusive agreement with Intellinetics. Over the past several months, the companies have worked closely together to translate the Intellivue™ software and related product collateral into Spanish and are currently marketing the software services. The initial Intellivue™ solution and product launch has begun in Mexico, Costa Rica, Panama, El Salvador, and Nicaragua.

Additionally, the Intellinetics agreement with MWAi will begin the company’s first foray into English speaking countries in Europe, with expansion expected to begin in the third quarter of 2012. Since Intellinetics has invested heavily in their template based best practice ECM solutions for a variety of industries, the current software will need very little upgrading aside from potential cultural differences. Perhaps even more exciting for Intellinetics and MWAi is the on-going efforts to convert the Intellivue™ cloud-based ECM software into a double-byte character set (DBCS), a software language typical for Japanese, Korean and Chinese translations. By employing DBCS, the Intellinetics software suite will be ready for clients in the Asia-Pacific Rim later this year.

“GlobalWise is positioning itself for record-breaking growth for the balance of 2012 and 2013,” proclaimed William. J. “BJ” Santiago, CEO of GlobalWise. “We have and will continue to recruit many strategic Partners to help us access more industries and markets. I expect we will have additional announcements in the near future regarding further domestic and international growth.”

“The great news with a cloud-based service delivery model, now available in both English and Spanish and soon for the Asian market, is the multitudes of ways to get our software into the hands of clients,” added Mr. Santiago. “Whether it’s integrating the ECM capabilities into an existing CRM or ERP system, implementation with multi-function printers or sold as a stand-alone solution, our software is dynamic enough to sit alongside almost any other architecture. The cloud delivery model provides a lower cost delivery approach without major capital expenditures that is perfect in the emerging ECM markets that previously did not have a cost effective solution.”

For additional information on GlobalWise Investments, visit the company’s website at www.GlobalWiseInvestments.com

Let us hear your thoughts: GlobalWise Investments, Inc. Message Board

NCI, Inc. (NCIT) Awarded $6.4 Million Task Order for Services to U.S. Army

Wednesday, June 27th, 2012

NCI announced yesterday that it has been awarded a competitive task order valued at $6.4 million to provide modeling, simulation, and network operations security center (NOSC) engineering support for the United States Army’s Signal Center of Excellence, Capabilities Development Integration Directorate, Experimentation Division located at Fort Gordon, GA. The period of performance begins July 1st and includes a base year and two option years.

According to the task order, NCI will develop modeling and simulation tools, information-dissemination management tools, data, products, analysis methods, and deliverables for the Government to use in support of the Army’s current and future communications experimentation and analytical requirements.

The task also includes maintaining the NOSC for the Battle Lab Collaborative Simulation Environment (BLCSE), which supports all the Training and Doctrine Command’s distributed experimentation events in a classified environment. BLCSE support includes day-to-day operations for approximately 24 distributed sites in the areas of system administration, collaboration tools, network design, network and data implementation, and information assurance requirements.

Brian J. Clark, NCI’s president, remarked, “NCI is very pleased to broaden our relationship with the Army through services we will provide to the U.S. Army’s Signal Center of Excellence at Fort Gordon. This award not only represents new business for NCI, but also a strategic entrée into a key new location. We look forward to supporting the mission of the Capabilities Development Integration Directorate, Experimentation Division.”

Let us hear your thoughts below: